Stereotactic Body Radiotherapy for the Treatment of Renal Tumors

The purpose of this study was to evaluate the response of actively growing renal masses to stereotactic body radiation therapy (SBRT). We retrospectively reviewed our institutional review board–approved kidney database and identified 4 patients who underwent SBRT, 15 Gy dose, for their rapidly growi...

Full description

Saved in:
Bibliographic Details
Published in:Urology case reports 2014-09, Vol.2 (5), p.147-149
Main Authors: Hanzly, Michael, Creighton, Terrance, Mix, Michael, Zeeck, Kevin, Fung-Kee-Fung, Simon, Singh, Anurag K., Schwaab, Thomas
Format: Article
Language:English
Subjects:
Kidney
Oncology
Radiotherapy
Tumor
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The purpose of this study was to evaluate the response of actively growing renal masses to stereotactic body radiation therapy (SBRT). We retrospectively reviewed our institutional review board–approved kidney database and identified 4 patients who underwent SBRT, 15 Gy dose, for their rapidly growing renal masses. Three patients had a decreased tumor size after radiation treatment by 20.8%, 38.1%, and 20%. The other patient had a size gain of 5.6%. This patient maintained a similar tumor growth rate before and after SBRT. Mean follow-up time was 13.8 months. SBRT represents an effective management option in select patients with larger rapidly growing kidney masses.
ISSN:2214-4420
2214-4420
DOI:10.1016/j.eucr.2014.05.011